Showing results (31-40 of 127) with videos related to
Sort By:
Pageof 13
Cancer Letters|July 1, 1985
Phase I pharmacologic study of a new Vinca alkaloid: navelbineG Mathé, P ReizensteinAnticancer Research|May 1, 1984
Differentiated treatment of myeloma. A non-randomised phase two studyE Osby, P ReizensteinScandinavian Journal of Haematology|October 1, 1977
Studies on human preleukaemia. I. Erythroblast and iron kinetics in aregenerative anaemia with hypercellular bone marrowR Hast, P ReizensteinDrugs Under Experimental and Clinical Research|January 1, 1986
Clinical trials of the treatment of minimal residual tumoursG Mathé, P Reizenstein, M EriguchiAnticancer Research|January 1, 1989
Effect of verapamil in vitro and in vivo on the accumulation of vincristine in leukemic cells from patients with low malignant lymphomaA Gruber, P Reizenstein, C PetersonAnticancer Research|September 1, 1986
Alternating combination chemotherapy does not delay development of refractoriness in myelomaE Osby, M Beksac, P ReizensteinRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Possible mechanisms of immunotherapy action in acute nonlymphocytic leukemia: macrophage production of colony-stimulating activityP Reizenstein, B Andersson, M BeranRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Staging of myeloma. A preliminary study of staging factors and treatment in different stagesE Osby, B Carlmark, P ReizensteinBulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapyG Mathé, P Reizenstein, M EriguchiScandinavian Journal of Clinical and Laboratory Investigation|November 1, 1975
Total body potassium measurements in 230 patients. A study of potassium depletionB Carlmark, D Kromhout, P ReizensteinPageof 13